On Aug. 7, 2020, Pfizer announced a multi-year agreement with Gilead Sciences to manufacture and supply Gileadﾒs investigational antiviral remdesivir, as one of multiple external manufacturing organizations supporting efforts to scale up supply of the investigational treatment for COVID-19. Under the terms of the agreement, Pfizer will provide contract manufacturing services at Pfizerﾒs McPherson, Kansas facility to manufacture and supply remdesivir for Gilead.